As efforts to address opioid addiction around the country increase, people with chronic pain and other disabilities continue to be left out of the conversation. This has resulted in increased barriers to effective pain management for people with chronic pain, discrimination against people who use opioids to manage their pain, and treatment and recovery options that are inaccessible to disabled people. The Chronic Pain / Opioids Task Force works to ensure that the voices of people with chronic pain and other disabilities are part of the ongoing national discussion and to develop a broader advocacy strategy for NCIL. If you are interested in joining the Chronic Pain & Opioids Task Force or want to learn more, contact Kristi McGarity at [email protected]
NCIL Statement of Principles on Chronic Pain and Opioids
Task Force Comments and Letters
- Comments – ACL Opioid Public Health Emergency Request For Information (February 2018)
- Comments – DEA Proposed Rule DEA-480 (May 2018)
- Letter to Oregon HERC regarding forced opioid tapers proposal (August 2018)
- Recommendations to the Pain Management Best Practices Inter-Agency Task Force (September 2018)
- Comments – Pain Management Best Practices Inter-Agency Task Force’s Draft Report (April 2019)
- Chronic Pain Advocacy Letter to Congress (June 2019)
- Comments – FDA docket #FDA-2020-N-1561-0001 on the opioid analgesics REMS program (February 2021)
- Comments – FDA public workshop and request for comments on Morphine Milligram Equivalents (MMEs) (August 2021)
- Community Advocacy Letter to Congress regarding CDC Updates to Guideline for Prescribing Opioids (April 2022)